| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3211149 | Journal of the American Academy of Dermatology | 2008 | 4 Pages |
Abstract
We report 3 cases of recalcitrant dermatomyositis that responded to the addition of daily leflunomide, a novel immunomodulatory drug that is currently used to treat rheumatoid arthritis. In our patients, leflunomide proved both safe and effective as adjuvant therapy in treating dermatomyositis.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
J. Scott Boswell, Melissa I. Costner,